Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000

Journal of Medical Microbiology

Volumn 54, Issue 6, 2005, Pages 567-574

  Elviss, Nicola C ^a,b   Owen, Robert J ^a   Breathnach, Aodhan ^c   Palmer, Catherine ^d   Shetty, Nandini ^d  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFSULODIN; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DYSPEPSIA; ERADICATION THERAPY; ETHNIC GROUP; FEMALE; HEALTH SURVEY; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION RISK; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE; UNITED KINGDOM;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CLARITHROMYCIN; DRUG RESISTANCE; DYSPEPSIA; EMIGRATION AND IMMIGRATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOSPITALS; HUMANS; LONDON; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S;

EID: 20344378683     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45896-0     Document Type: Article

References (30)

1. Aceti, A., Are, R., Sabino, G., Fenu, L., Pasquazzi, C., Quaranta, G., Zechini, B. & Terrosu, P. (2004). Helicobacter pylori active infection in patients with acute coronary heart disease. J Infect 49, 8-12.
2. Andrews, J. (2003). BSAC Disc Diffusion Method for Antimicrobial Susceptibility Testing, Version 2.1.4. Birmingham, UK: British Society for Antimicrobial Chemotherapy.
3. Banatvala, N., Davies, G. R., Abdi, Y., Clements, L., Rampton, D. S., Hardie, J. M. & Feldman, R. A. (1994). High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 35, 1562-1566.
4. Cameron, E. A. B., Powell, K. U., Baldwin, L., Jones, P., Bell, G. D. & Williams, S. G. J. (2004). Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001. J Med Microbiol 53, 535-538.
5. Chisholm, S. A. & Owen, R. J. (2003). Mutations in Helicobacter pylori rdxA gene sequences may not contribute to metronidazole resistance. J Antimicrob Chemother 51, 995-999.
6. Chisholm, S. A., Teare, E. L., Patel, B. & Owen, R. J. (2002). Determination of Helicobacter pylori vacA allelic types by single-step multiplex PCR. Lett Appl Microbiol 35, 42-46.
7. Dore, M. P., Leandro, G., Realdi, G., Sepulveda, A. R. & Graham, D. Y. (2000). Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci 45, 68-76.
8. Duck, W. M., Sobel, J., Pruckler, J. M. & 21 other authors (2004). Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis 10, 1088-1094.
9. Elviss, N. C., Owen, R. J., Xerry, J., Walker, M. & Davies, K. (2004a). Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J Antimicrob Chemother 54, 435-440.
10. Elviss, N. C., Lawson, A. J. & Owen, R. J. (2004b). Application of 3′-mismatched reverse primer PCR compared with real-time PCR and PCR-RFLP for the rapid detection of 23S rDNA mutations associated with clarithromycin resistance in Helicobacter pylori. Int J Antimicrob Agents 23, 349-355.
11. Glupczynski, Y., Mégraud, F., López-Brea, M. & Andersen, L. P. (2001). European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 20, 820-823.
12. Glupczynski, Y., Broutet, N., Cantagrel, A., Andersen, L. P., Alarcón, T., López-Brea, M. & Mégraud, F. (2002). Comparison of the E Test and agar dilution method for antimicrobial susceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 21, 549-552.
13. Harris, A. & Misiewicz, J. J. (2001). ABC of the upper gastrointestinal tract. Management of Helicobacter pylori infection. BMJ 323, 1047-1050.
14. Heep, M., Kist, M., Strobel, S., Beck, D. & Lehn, N. (2000). Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis 19, 538-541.
15. Kist, M. & Glocker, E. (2004). ResiNet - a nationwide German sentinel study for surveillance and analysis of antimicrobial resistance in Helicobacter pylori. Eurosurveillance 9, 44-45.
16. Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P., Jones, R., Axon, A., Graham, D. Y., Tytgat, G. & European Helicobacter pylori Study Group (2002). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16, 167-180.
17. Meyer, J. M., Silliman, N. P., Wang, W. & 7 other authors (2002). Risk factors for Helicobacter pylori resistance in the United States: the Surveillance of H. pylori Antimicrobial Resistance Partnership (SHARP) study, 1993-1999. Ann Intern Med 136, 13-24.
18. McNulty, C., Owen, R., Tompkins, D., Hawtin, P., McColl, K., Price, A., Smith, G., Teare, L. & PHLS Helicobacter Working Group (2002). Helicobacter pylon susceptibility testing by disc diffusion. J Antimicrob Chemother 49, 601-609.
19. Mégraud, F. (2001). Resistance of Helicobacter pylori to antibiotics and its impact on treatment options. Drug Resistance Updates 4, 178-186.
20. NCCLS (1999). Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard M7-A5: Informational Supplement M100-S10. Wayne, PA: National Committee for Clinical Laboratory Standards.
21. NICE (2003). Dyspepsia: Managing Adult Patients in Primary Care, 2nd draft. London: National Guideline Research and Development Unit. www.nice.org.uk (accessed 23 August 2004).
22. Owen, R. J. (2002). Molecular testing for antibiotic resistance in Helicobacter pylori. Gut 50, 285-289.
23. Owen, R. J., Xerry, J., Peters, T. M. & Teare, E. L. (2002). Surveillance and clinical relevance of vacA genotypes of Helicobacter pylori infecting dyspeptic patients in mid-Essex. Commun Dis Public Health 5, 106-111.
24. Parsons, H. K., Carter, M. J., Sanders, D. S., Winstanley, T. & Lobo, A. J. (2001). Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Aliment Pharmacol Ther 15, 1473-1478.
25. SIGN (2002). Dyspepsia: A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network. http://www.sign.ac.uk/pdf/sign68. pdf (accessed 8 June 2004).
26. Suerbaum, S. & Michetti, P. (2002). Helicobacter pylori infection. N Eng J Med 347, 1175-1186.
27. Teare, L., Peters, T., Saverymuttu, S., Owen, R. & Tiwari, I. (1999). Antibiotic resistance in Helicobacter pylori. Lancet 353, 241-242.
28. Thyagarajan, S. P., Ray, P., Das, B. K. & 10 other authors (2003). Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicentric study. J Gastroenterol Hepatol 18, 1373-1378.
29. Vyse, A. J., Gay, N. J., Hesketh, L. M., Andrews, N. J., Marshall, B., Thomas, H. I., Morgan-Capner, P. & Miller, E. (2002). The burden of Helicobacter pylori infection in England and Wales. Epidemiol Infect 128, 411-417.
30. Wolle, K., Leodolter, A., Malfertheiner, P. & Konig, W. (2002). Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol 51, 705-709.